COURSE DIRECTOR
Matthew T. Hoerth, M.D.

DESCRIPTION
This is a weekly clinical case conference in which all patients admitted through the epilepsy monitoring unit are discussed for potential epilepsy surgery. This is a multidisciplinary conference as well. Results of the conference case discussion directly impact the patient.
 
TARGET AUDIENCE
This course is intended primarily for epilepsy neurologists, neuropsychologists, neurosurgeons, and EEG technologists.

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:

• Identify appropriate patients for surgical intervention.
• Apply ways in which safety can be improved in the epilepsy monitoring unit
• Assess newly approved epilepsy medications
• Create individualized prognostic information tailored to the individual patient

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

CREDIT STATEMENT(S)
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAPA

Mayo Clinic College of Medicine and Science has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

DISCLOSURE SUMMARY
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities.  All who are in a position to control the content are required to disclose all financial relationships with any ineligible company.   Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.

Listed below are individuals with control of the content of this program who have disclosed...

Relevant financial relationship(s) with ineligible companies:
None

All relevant financial relationships have been mitigated.

No relevant financial relationship(s) with ineligible companies:
Ejerzain Aniles Renova, P.A.-C.
Matthew Hoerth, M.D.
Katherine H. Noe, M.D., Ph.D.
Vada L. Howard (Coordinator)
Erin L. Quackenbush, M.P.H. (Coordinator) 

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded will appear on your Transcript.

QUESTIONS?
Contact Vada Howard